Slope
2 known investors
Slope provides software to manage the biospecimen lifecycle for clinical research sites, enabling researchers and sponsors to track and oversee biological samples at scale throughout clinical trials. The platform serves clinical research sites, sponsors, and contract research organizations conducting clinical trials.
Enterprise SoftwareHealthtechMedical DevicesSaaS
Founders & leadership
RF
Rust FelixChief Executive Officer and cofounder
Investors · 2
Funding
SEC filings, press & company announcements$65M disclosed across 1 round · 2024
- $65MraisedJul 2024 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Slope do?
- Slope provides software to manage the biospecimen lifecycle for clinical research sites, enabling researchers and sponsors to track and oversee biological samples at scale throughout clinical trials. The platform serves clinical research sites, sponsors, and contract research organizations conducting clinical trials.
- Who founded Slope?
- Slope was founded by Rust Felix.
- Who are Slope's investors?
- Slope's investors include Breyer Capital, Dynamo Ventures.
- How much funding has Slope raised?
- Slope has disclosed $65M raised across 1 round.